Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity

Science. 2015 Jan 16;347(6219):269-73. doi: 10.1126/science.1258100. Epub 2014 Nov 27.

Abstract

Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-α (IFN-α) and IFN-β prevented the systemic spread of murine norovirus (MNoV), only IFN-λ controlled persistent enteric infection. Infection-dependent induction of IFN-λ was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-λ cured mice in a manner requiring nonhematopoietic cell expression of the IFN-λ receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-λ for curing virus infections in the gastrointestinal tract.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • Animals
  • Caliciviridae Infections / drug therapy*
  • Caliciviridae Infections / immunology*
  • Caliciviridae Infections / virology
  • Capsid Proteins / immunology
  • Capsid Proteins / metabolism
  • Cells, Cultured
  • Cytokines / biosynthesis
  • Cytokines / immunology*
  • Cytokines / therapeutic use*
  • Feces / virology
  • Gastroenteritis / drug therapy
  • Gastroenteritis / immunology*
  • Gastroenteritis / virology
  • Immunity, Innate
  • Interferon-alpha / biosynthesis
  • Interferon-alpha / immunology
  • Interferon-beta / biosynthesis
  • Interferon-beta / immunology
  • Mice
  • Mice, Inbred C57BL
  • Norovirus / immunology*
  • Norovirus / physiology*
  • Virus Replication
  • Virus Shedding

Substances

  • Capsid Proteins
  • Cytokines
  • Interferon-alpha
  • interferon-lambda protein, mouse
  • Interferon-beta